-
EP3969907
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3969907
| EP3969907 - INTERFERENCE-SUPPRESSED PHARMACOKINETIC IMMUNOASSAY [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 17.05.2024 Database last updated on 22.08.2024 | |
| Former | Request for examination was made Status updated on 18.02.2022 | ||
| Former | The international publication has been made Status updated on 20.11.2020 | ||
| Former | unknown Status updated on 27.05.2020 | Most recent event Tooltip | 11.06.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2022/12] | Inventor(s) | 01 /
JORDAN, Gregor c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 02 /
LUTZ, Achim c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 03 /
VIERT, Maria c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | [2022/12] | Representative(s) | Skolaut, Alexander Roche Diagnostics GmbH Patent Department (LPP.....6164) Nonnenwald 2 82377 Penzberg / DE | [2022/12] | Application number, filing date | 20726324.5 | 11.05.2020 | [2022/12] | WO2020EP62965 | Priority number, date | EP20190174196 | 13.05.2019 Original published format: EP 19174196 | [2022/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020229378 | Date: | 19.11.2020 | Language: | EN | [2020/47] | Type: | A1 Application with search report | No.: | EP3969907 | Date: | 23.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.11.2020 takes the place of the publication of the European patent application. | [2022/12] | Search report(s) | International search report - published on: | EP | 19.11.2020 | Classification | IPC: | G01N33/543, G01N33/68 | [2022/12] | CPC: |
G01N33/54393 (EP);
G01N33/5306 (US);
G01N33/54306 (EP);
G01N33/686 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/12] | Title | German: | INTERFERENZUNTERDRÜCKTES PHARMAKOKINETISCHES IMMUNOASSAY | [2022/12] | English: | INTERFERENCE-SUPPRESSED PHARMACOKINETIC IMMUNOASSAY | [2022/12] | French: | DOSAGE IMMUNOLOGIQUE PHARMACOCINÉTIQUE À INTERFÉRENCE SUPPRIMÉE | [2022/12] | Entry into regional phase | 13.12.2021 | National basic fee paid | 13.12.2021 | Designation fee(s) paid | 13.12.2021 | Examination fee paid | Examination procedure | 13.12.2021 | Examination requested [2022/12] | 13.12.2021 | Date on which the examining division has become responsible | 25.05.2022 | Amendment by applicant (claims and/or description) | 17.05.2024 | Despatch of a communication from the examining division (Time limit: M04) | 10.06.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 21.03.2022 | Renewal fee patent year 03 | 21.03.2023 | Renewal fee patent year 04 | 15.03.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US4828981 (MAGGIO EDWARD T [US]); | [I]US2015198608 (STUBENRAUCH KAY-GUNNAR [DE], et al); | by applicant | EP0061888 | US4676980 | WO9005301 | WO9011511 | WO9214138 | WO9308829 | EP0580979 | WO9627011 | US5731168 | WO9850431 | WO2007110205 | EP1870459 | WO2007147901 | WO2009080251 | WO2009080252 | WO2009080253 | WO2009080254 | WO2009089004 | WO2010112193 | WO2010115589 | WO2010129304 | WO2010136172 | WO2010145792 | WO2010145793 | WO2011090754 | WO2011143545 | WO2012058768 | WO2013096291 | WO2013157954 |